Adicet Bio, Inc. — Director's Dealing 2020

Sep 18, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-15

Reporting Person: Harvey Brian Nicholas (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Option (right-to-buy)	$16.11	2030-09-17	Common Stock (195898)		Direct

Footnotes

F1: 25% of the shares of common stock subject to the option shall vest twelve (12) months after the vesting commencement date, and 1/36th of the remaining unvested shares subject to the option shall vest on each of the next thirty-six (36) monthly anniversaries of the vesting commencement date thereafter, provided that the reporting person remains in continuous service as of the applicable vesting date.